|
US6451784B1
(en)
*
|
1996-12-30 |
2002-09-17 |
Battellepharma, Inc. |
Formulation and method for treating neoplasms by inhalation
|
|
CA2346029A1
(en)
*
|
1998-10-02 |
2000-04-13 |
Anthony R. Imondi |
Inhalation chemotherapy for prevention and treatment of metastatic tumors in the lung
|
|
AU2986800A
(en)
*
|
1999-02-08 |
2000-08-25 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Methods of inhibiting the hgf-met-upa-plasmin network
|
|
US7311924B2
(en)
*
|
1999-04-01 |
2007-12-25 |
Hana Biosciences, Inc. |
Compositions and methods for treating cancer
|
|
GB9920548D0
(en)
*
|
1999-08-31 |
1999-11-03 |
Rhone Poulenc Rorer Sa |
Treatment of hepatocellular carcinoma
|
|
US6651655B1
(en)
*
|
2000-01-18 |
2003-11-25 |
Quadrant Technologies Limited |
Inhaled vaccines
|
|
EP1267914B2
(en)
|
2000-02-04 |
2013-11-06 |
Children's Hospital Research Foundation |
Use of lysosomal acid lipase for treating atherosclerosis and related diseases
|
|
ATE466611T1
(de)
*
|
2000-04-03 |
2010-05-15 |
Battelle Memorial Institute |
Ausgabevorrichtungen und flüssigformulierungen
|
|
US8071740B2
(en)
|
2000-11-17 |
2011-12-06 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
|
AU2003222427B8
(en)
*
|
2000-11-17 |
2010-04-29 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same
|
|
US20100282634A1
(en)
*
|
2000-11-17 |
2010-11-11 |
Dror Harats |
Promoters Exhibiting Endothelial Cell Specificity and Methods of Using Same for Regulation of Angiogenesis
|
|
US20070286845A1
(en)
*
|
2000-11-17 |
2007-12-13 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
|
US8039261B2
(en)
*
|
2000-11-17 |
2011-10-18 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
|
US6838452B2
(en)
|
2000-11-24 |
2005-01-04 |
Vascular Biogenics Ltd. |
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
|
|
MXPA03004883A
(es)
*
|
2000-12-01 |
2004-05-04 |
Battelle Memorial Institute |
Metodo para la estabilizacion de biomoleculas (por ejemplo, insulina) en formulaciones liquidas.
|
|
EP1401875A4
(en)
*
|
2001-05-04 |
2005-01-26 |
Univ Utah Res Found |
HYALURONIC ACID-CONTAINING BIOKON JUGATES: TARGETED DELIVERY OF ANTIBODIES TO CANCER CELLS
|
|
US7585493B2
(en)
|
2001-05-24 |
2009-09-08 |
Alexza Pharmaceuticals, Inc. |
Thin-film drug delivery article and method of use
|
|
US7090830B2
(en)
|
2001-05-24 |
2006-08-15 |
Alexza Pharmaceuticals, Inc. |
Drug condensation aerosols and kits
|
|
US20070122353A1
(en)
|
2001-05-24 |
2007-05-31 |
Hale Ron L |
Drug condensation aerosols and kits
|
|
US20030051728A1
(en)
|
2001-06-05 |
2003-03-20 |
Lloyd Peter M. |
Method and device for delivering a physiologically active compound
|
|
US7458374B2
(en)
|
2002-05-13 |
2008-12-02 |
Alexza Pharmaceuticals, Inc. |
Method and apparatus for vaporizing a compound
|
|
US20030059375A1
(en)
*
|
2001-08-20 |
2003-03-27 |
Transave, Inc. |
Method for treating lung cancers
|
|
CA2457148A1
(en)
*
|
2001-08-20 |
2003-02-27 |
Transave, Inc. |
Treatment of cancers by inhalation of stable platinum-containing formulations
|
|
JP2005508354A
(ja)
*
|
2001-10-15 |
2005-03-31 |
クリチテック インコーポレーテッド |
水に溶けにくい薬物の送込み用組成物および方法並びに治療方法
|
|
CN100506284C
(zh)
*
|
2001-10-19 |
2009-07-01 |
脉管生物生长有限公司 |
多核苷酸构建体、药物组合物以及靶向的下调血管生成和抗癌的治疗方法
|
|
WO2003066005A2
(en)
*
|
2002-02-08 |
2003-08-14 |
Conforma Therapeutics Corporation |
Ansamycins having improved pharmacological and biological properties
|
|
CA2477982A1
(en)
*
|
2002-03-05 |
2003-09-18 |
Transave, Inc. |
Methods for entrapment of bioactive agent in a liposome or lipid complex
|
|
ITPI20020018A1
(it)
*
|
2002-03-28 |
2002-06-26 |
Azienda Ospedaliera Pisana |
Ventilazione polmonare a variazione di flusso
|
|
GB0208516D0
(en)
*
|
2002-04-15 |
2002-05-22 |
Univ Liverpool |
Chemotherapy
|
|
US20050169883A1
(en)
*
|
2002-05-06 |
2005-08-04 |
Prestwich Glenn D. |
Preblocking with non-ha gags increases effectiveness of ha conjugated anticancer agents
|
|
US7677411B2
(en)
*
|
2002-05-10 |
2010-03-16 |
Oriel Therapeutics, Inc. |
Apparatus, systems and related methods for processing, dispensing and/or evaluatingl dry powders
|
|
US6985798B2
(en)
|
2002-05-10 |
2006-01-10 |
Oriel Therapeutics, Inc. |
Dry powder dose filling systems and related methods
|
|
US6889690B2
(en)
*
|
2002-05-10 |
2005-05-10 |
Oriel Therapeutics, Inc. |
Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages
|
|
US7118010B2
(en)
|
2002-05-10 |
2006-10-10 |
Oriel Therapeutics, Inc. |
Apparatus, systems and related methods for dispensing and /or evaluating dry powders
|
|
WO2004003707A2
(en)
*
|
2002-06-27 |
2004-01-08 |
Oriel Therapeutics, Inc. |
Apparatus and methods for dispensing dry powders
|
|
US9186322B2
(en)
|
2002-08-02 |
2015-11-17 |
Insmed Incorporated |
Platinum aggregates and process for producing the same
|
|
BRPI0313191A2
(pt)
*
|
2002-08-02 |
2016-11-08 |
Transave Inc |
composição e processo para produzir um agregado de platina e formulação farmacêutica
|
|
US7718189B2
(en)
*
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
|
US7879351B2
(en)
*
|
2002-10-29 |
2011-02-01 |
Transave, Inc. |
High delivery rates for lipid based drug formulations, and methods of treatment thereof
|
|
SI1581236T1
(sl)
*
|
2002-10-29 |
2014-02-28 |
Insmed Incorporated Princeton Corporate Plaza |
Zadržano sproščanje antiinfektivov
|
|
US20060179491A1
(en)
*
|
2002-11-12 |
2006-08-10 |
Brian Graham |
Process for treating non-human animals
|
|
US7353533B2
(en)
|
2002-12-18 |
2008-04-01 |
Novell, Inc. |
Administration of protection of data accessible by a mobile device
|
|
US7185650B2
(en)
*
|
2002-12-19 |
2007-03-06 |
Arie Huber |
Systems and methods for determining a minimum effective dose of an inhaled drug for an individual patient at a given time
|
|
US20060148776A1
(en)
*
|
2003-03-13 |
2006-07-06 |
Conforma Therapeutics Corporation |
Drug formulations having long and medium chain triglycerides
|
|
US20040187864A1
(en)
*
|
2003-03-24 |
2004-09-30 |
Cindet, Llc |
Inhalation device and method
|
|
US20040234914A1
(en)
|
2003-05-21 |
2004-11-25 |
Alexza Molecular Delivery Corporation |
Percussively ignited or electrically ingnited self-contained heating unit and drug-supply unit employing same
|
|
SI2263694T1
(sl)
*
|
2003-09-25 |
2013-09-30 |
Astellas Pharma Inc. |
Antitumorsko sredstvo, ki obsega inhibitor histon-deacetilaze FK228 in inhibitor topoizomeraze II doksorubicin
|
|
US7377277B2
(en)
*
|
2003-10-27 |
2008-05-27 |
Oriel Therapeutics, Inc. |
Blister packages with frames and associated methods of fabricating dry powder drug containment systems
|
|
US7451761B2
(en)
*
|
2003-10-27 |
2008-11-18 |
Oriel Therapeutics, Inc. |
Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances
|
|
EP1729786A4
(en)
*
|
2004-03-18 |
2008-03-26 |
Transave Inc |
ADMINISTRATION OF CISPLATIN BY INHALATION
|
|
AU2005245018A1
(en)
*
|
2004-05-21 |
2005-12-01 |
Transave, Inc. |
Treatment of lung diseases and pre-lung disease conditions
|
|
US7540286B2
(en)
|
2004-06-03 |
2009-06-02 |
Alexza Pharmaceuticals, Inc. |
Multiple dose condensation aerosol devices and methods of forming condensation aerosols
|
|
EP1781360A1
(en)
|
2004-08-12 |
2007-05-09 |
Alexza Pharmaceuticals, Inc. |
Aerosol drug delivery device incorporating percussively activated heat packages
|
|
US20060045849A1
(en)
*
|
2004-08-24 |
2006-03-02 |
Farhan Taghizadeh |
Method of customizing the fragrance of nasal medications
|
|
EP1811963A4
(en)
*
|
2004-11-08 |
2010-01-06 |
Transave Inc |
METHOD FOR CREATING TREATMENT WITH INTRAPERITONEALLY APPLIED PLATINUM COMPOUND FORMULATIONS ON LIPID BASIS
|
|
BRPI0608661A2
(pt)
*
|
2005-04-07 |
2010-01-19 |
Conforma Therapeutics Corp |
formulaÇço farmacÊutica, uso de formulaÇço farmacÊutica, e, mÉtodo de preparaÇço de uma formulaÇço farmacÊutica
|
|
US20060283742A1
(en)
*
|
2005-06-16 |
2006-12-21 |
Canel Lightning Co. Ltd. |
Multi-lamp display packaging for lamps with collapsible lampshades
|
|
US20090180964A1
(en)
*
|
2005-06-24 |
2009-07-16 |
Rao Papineni |
Transmucosal delivery of optical, spect, multimodal,drug or biological cargo laden nanoparticle(s) in small animals or humans
|
|
US20070190180A1
(en)
*
|
2005-11-08 |
2007-08-16 |
Pilkiewicz Frank G |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intravenously
|
|
US9107824B2
(en)
|
2005-11-08 |
2015-08-18 |
Insmed Incorporated |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
US20070190181A1
(en)
*
|
2005-11-08 |
2007-08-16 |
Pilkiewicz Frank G |
Methods of treating cancer with lipid-based platinum compound forumulations administered intravenously
|
|
WO2007056264A2
(en)
*
|
2005-11-08 |
2007-05-18 |
Transave, Inc. |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
WO2007064658A2
(en)
*
|
2005-11-30 |
2007-06-07 |
Transave, Inc. |
Safe and effective methods of administering therapeutic agents
|
|
JP2009518302A
(ja)
*
|
2005-12-01 |
2009-05-07 |
コンフォーマ・セラピューティクス・コーポレイション |
アンサマイシン含有組成物
|
|
US8226975B2
(en)
|
2005-12-08 |
2012-07-24 |
Insmed Incorporated |
Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
|
|
GB0526552D0
(en)
*
|
2005-12-29 |
2006-02-08 |
Morvus Technology Ltd |
New use
|
|
WO2007139930A2
(en)
*
|
2006-05-26 |
2007-12-06 |
Bayer Healthcare Llc |
Drug combinations with substituted diaryl ureas for the treatment of cancer
|
|
US10821132B2
(en)
|
2007-02-26 |
2020-11-03 |
Heartbeet Ltd |
Compositions of nitrates and methods of use thereof
|
|
HUE031982T2
(en)
|
2007-02-26 |
2017-08-28 |
Heartbeet Ltd |
Performance enhancing composition and use thereof
|
|
US11759477B2
(en)
|
2007-02-26 |
2023-09-19 |
Heartbeet Ltd. |
Compositions of nitrates and methods of use thereof
|
|
US10842813B2
(en)
|
2007-02-26 |
2020-11-24 |
Heartbeet Ltd |
Compositions of nitrates and methods of use thereof
|
|
EP2121088B1
(en)
|
2007-03-09 |
2016-07-13 |
Alexza Pharmaceuticals, Inc. |
Heating unit for use in a drug delivery device
|
|
WO2008134630A1
(en)
*
|
2007-04-30 |
2008-11-06 |
Apt Pharmaceuticals |
Dexrazoxane compounds for cardioprotection
|
|
US20080275036A1
(en)
*
|
2007-05-02 |
2008-11-06 |
Apt Pharmaceuticals, Inc. |
Prevention and treatment of cardiac conditions
|
|
WO2008137717A1
(en)
|
2007-05-04 |
2008-11-13 |
Transave, Inc. |
Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
|
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
|
WO2009079078A1
(en)
|
2007-12-14 |
2009-06-25 |
Labogroup S.A.S. |
Delivering aerosolizable food products
|
|
JP2012505228A
(ja)
*
|
2008-10-07 |
2012-03-01 |
レクサン ファーマシューティカルズ インコーポレイテッド |
Ｈｐｍａ−ドセタキセルまたはゲムシタビンコンジュゲートおよびその使用
|
|
JP5749273B2
(ja)
|
2009-10-13 |
2015-07-15 |
レクサン ファーマシューティカルズ インコーポレイテッド |
抗がん剤送達のためのポリマー系
|
|
WO2013177226A1
(en)
|
2012-05-21 |
2013-11-28 |
Insmed Incorporated |
Systems for treating pulmonary infections
|
|
ES2848025T3
(es)
|
2012-09-04 |
2021-08-05 |
Eleison Pharmaceuticals LLC |
Prevención de la recidiva pulmonar del cáncer con cisplatino complejado con lípidos
|
|
JP6419710B2
(ja)
|
2012-11-20 |
2018-11-07 |
スペクトラム ファーマシューティカルズ |
治療的使用のためのリポソーム封入ビンクリスチンの調製のための改良法
|
|
JP6529438B2
(ja)
|
2012-11-29 |
2019-06-12 |
インスメッド インコーポレイテッド |
安定化されたバンコマイシン処方物
|
|
EP2931042B1
(en)
|
2012-12-13 |
2021-04-28 |
CytRx Corporation |
Anthracycline formulations
|
|
JP2016521705A
(ja)
|
2013-06-05 |
2016-07-25 |
サイトレックス コーポレイション |
がんを処置するための細胞傷害剤
|
|
CA2919837A1
(en)
*
|
2013-08-02 |
2015-02-05 |
Children's Hospital Medical Center |
Compositions and methods for treating disease states associated with activated t cells and/or b cells
|
|
KR102256576B1
(ko)
|
2013-10-08 |
2021-05-27 |
에이아이 테라퓨틱스, 인코포레이티드 |
림프관평활근종증의 치료를 위한 라파마이신
|
|
AU2015217349A1
(en)
|
2014-02-11 |
2016-09-08 |
AI Therapeutics, Inc. |
Rapamycin for the treatment of lymphangioleiomyomatosis
|
|
US10307371B2
(en)
|
2014-02-11 |
2019-06-04 |
AI Therapeutics, Inc. |
Rapamycin for the treatment of lymphangioleiomyomatosis
|
|
NZ724756A
(en)
|
2014-04-04 |
2023-07-28 |
Ai Therapeutics Inc |
An inhalable rapamycin formulation for treating age-related conditions
|
|
TWI601542B
(zh)
|
2014-04-18 |
2017-10-11 |
林信湧 |
一種用於治療肺癌之吸入式醫藥組成物及其備製方法
|
|
ES2926985T3
(es)
|
2014-05-15 |
2022-10-31 |
Insmed Inc |
Métodos para tratar infecciones pulmonares micobacterianas no tuberculosas
|
|
EP3209330B1
(en)
|
2014-10-07 |
2022-02-23 |
AI Therapeutics, Inc. |
An inhalable sirolimus formulation for the treatment of pulmonary hypertension
|
|
MA40910A
(fr)
|
2014-11-07 |
2017-09-12 |
Civitas Therapeutics Inc |
Poudres de rapamycine pour administration pulmonaire
|
|
WO2016130645A1
(en)
|
2015-02-10 |
2016-08-18 |
Lam Therapeutics, Inc. |
Rapamycin for the treatment of lymphangioleiomyomatosis
|
|
US10751319B2
(en)
|
2015-06-04 |
2020-08-25 |
Crititech, Inc. |
Collection device and methods for use
|
|
TWI678213B
(zh)
|
2015-07-22 |
2019-12-01 |
美商史倍壯製藥公司 |
用於長春新鹼硫酸鹽脂質體注射之即可使用的調配物
|
|
CN108351862B
(zh)
|
2015-08-11 |
2023-08-22 |
科格诺亚公司 |
利用人工智能和用户输入来确定发育进展的方法和装置
|
|
US11972336B2
(en)
|
2015-12-18 |
2024-04-30 |
Cognoa, Inc. |
Machine learning platform and system for data analysis
|
|
EP3439635B1
(en)
|
2016-04-04 |
2020-12-09 |
Crititech, Inc. |
Formulations for solid tumor treatment
|
|
EP3539033B1
(en)
|
2016-11-14 |
2024-10-02 |
Cognoa, Inc. |
Methods and apparatus for evaluating developmental conditions and providing control over coverage and reliability
|
|
US10874768B2
(en)
*
|
2017-01-20 |
2020-12-29 |
Covidien Lp |
Drug eluting medical device
|
|
US20220254461A1
(en)
*
|
2017-02-09 |
2022-08-11 |
Cognoa, Inc. |
Machine learning algorithms for data analysis and classification
|
|
GB2575740A
(en)
*
|
2017-02-09 |
2020-01-22 |
Congoa Inc |
Platform and system for digital personalized medicine
|
|
SG10201913649TA
(en)
|
2017-06-09 |
2020-03-30 |
Crititech Inc |
Treatment of epithelial cysts by intracystic injection of antineoplastic particles
|
|
KR102303762B1
(ko)
*
|
2017-06-14 |
2021-09-23 |
크리티테크, 인크. |
폐 장애의 치료 방법
|
|
US10894019B2
(en)
|
2017-08-15 |
2021-01-19 |
University Of South Carolina |
Drug delivery system and method for targeting cancer stem cells
|
|
BR112020005814A2
(pt)
|
2017-10-03 |
2020-09-24 |
Crititech, Inc. |
administração local de partículas antineoplásicas em combinação com administração sistêmica de agentes imunoterapêuticos para o tratamento de câncer
|
|
MX2020007997A
(es)
|
2018-02-02 |
2020-12-03 |
Alexza Pharmaceuticals Inc |
Dispositivo electrico de aerosol de condensacion.
|
|
EP3773505A4
(en)
|
2018-03-30 |
2021-12-22 |
Insmed Incorporated |
PROCESS FOR THE CONTINUOUS MANUFACTURING OF LIPOSOMAL MEDICINAL PRODUCTS
|
|
KR102643554B1
(ko)
|
2019-03-22 |
2024-03-04 |
코그노아, 인크. |
개인 맞춤식 디지털 치료 방법 및 디바이스
|
|
US11672767B2
(en)
|
2019-05-13 |
2023-06-13 |
University Of South Carolina |
Enzymatically cleavable self-assembled nanoparticles for morphogen delivery
|
|
WO2021040673A1
(en)
*
|
2019-08-26 |
2021-03-04 |
Alain Martin |
Methods for the treatment of chronic hypoxemia and inhibiting lung fibrosis in patients with pulmonary fibrosis with and without copd
|
|
CN111067879B
(zh)
*
|
2020-01-20 |
2022-08-09 |
珠海瑞思普利医药科技有限公司 |
一种抗肿瘤组合物吸入粉雾剂及其制备方法
|
|
US20240120050A1
(en)
*
|
2022-10-07 |
2024-04-11 |
Insight Direct Usa, Inc. |
Machine learning method for predicting a health outcome of a patient using video and audio analytics
|